$15 million in Series E investment was raised by Wilmington, DE-based Truveris, a firm that specializes in pharmaceutical cost savings and program execution.
Investors
- Canaan Partners
- New Leaf Venture Partners
Use of funds
The money will be used by the business to help its next phase of corporate development and operational expansion across all employers in the country.
About Truveris
Truveris is a healthcare technology firm headed by CEO Nanette Oddo with a primary goal of cutting pharmacy costs. It has developed a stand-alone, data-driven technology platform that fully transparently sets PBM pricing and stimulates competition to lower employer expenses. Its solutions, which offer deep insights, comparative procurement, 100% claims analysis, and member engagement tools, replace conventional pharmaceutical procurement and renewal approaches for self-insured companies.
“This financing round represents a further validation of our industry-leading solutions and ongoing growth potential. We’ll keep improving the Truveris platform, and in collaboration with our esteemed customers and business partners, we’ll improve pharmaceutical spending for employers and plan participants while also cutting costs.$15 million in Series E investment was raised by Wilmington, DE-based Truveris, a firm that specializes in pharmaceutical cost savings and program execution.”
Nanette Oddo
